ORICORIC Pharmaceuticals, Inc.
$12.02-15% 1Y
$12.02
$7.4752 weeks$14.67
The financials
ORIC Pharmaceuticals, Inc. by the numbers
The next results filing is expected around Nov 12, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Operating income | −$45M | −$39M | n/a |
| Net income | −$41M | −$36M | n/a |
| Diluted EPS | −$0.38 | −$0.47 | n/a |